 RAPTA compounds have low general toxicity that apparently reduces the side-effects associated with chemotherapy.Ruthenium diamine complexes are of interest as potential anticancer drugs.RAED compounds are ruthenium–arene complexes bearing the 1,2-ethylenediamine ligand.